Essex Corp.

Ticker ... Yesterday's

Symbol ... Cls. ... Chg.

ESEX ...... 2 ..... unch.

Period ended

6/26 ...... ..... 2nd qtr. ... Year ago ... Chg.

Revenue ... ..... $3,829 ...... $2,307 ..... +65.9%

Net Income ...... $(365)* ..... $(508) ....... --

Primary EPS .... $(0.20)* ..... $(0.28) ...... --

.......... ....... 6 mos. ..... Year ago ... Chg.

Revenue .......... $7,656 ...... $4,614 .... +65.9%

Net Income ....... $(359)* ..... $(803) ...... --

Primary EPS ..... $(0.20)* ..... $(0.45) ..... --

* Includes charge of $375,000, or 21 cents per share, related to settlement of rent dispute.

Figures in thousands (except per share data.)

Human Genome Sciences Inc.

Ticker ..... Yesterday's

Symbol ..... Cls. ... Chg.

HGSI ....... 14 1/4 -1/16

Period ended

6/30/94 ....... 2nd qtr. ... Year ago ... Chg.

Revenue ....... $12,552 ..... $12,000 ... +4.6%

Net Income ..... $3,480 ...... $6,429 ... -45.9%

Primary EPS* .... $0.22 ....... $0.60 ... -63.3%

........ ....... 6 mos. ... Year ago ... Chg.

Revenue ....... $25,052 ... $13,000 .... +92.7%

Net Income ..... $7,507 .... $4,388 .... +71.1%

Primary EPS* .... $0.48 ..... $0.41 .... +17.1%

* The company, which went public in December 1993, increased the number of weighted average shares outstanding to 15.6 million from 10.1 million over the past year.

Figures in thousands (except per share data.)